A federally funded research initiative will enable researchers at Oregon Health & Science University and other organizations to assess the safety and effectiveness of state-regulated access to ...

Psyence Biomedical Ltd. ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing nature-derived psilocybin ...

Researchers led by Dr. Claire Foldi at Monash University have discovered that psilocybin, the psychoactive compound found in ...

A federally funded research initiative will enable researchers at Oregon Health & Science University and other organizations ...

Researchers discovered that psilocybin produces subtle, context-dependent effects on social behavior and IL-6 mediated inflammation in female mice. Activity-based anorexia (ABA) mice exhibited ...

A Queensland not-for-profit mental health clinic that delivers novel therapies such as ketamine and psilocybin is expanding ...

An Alaska psychedelics task force is recommending that the state move forward with plans to provide regulated access to ...

The Put Option Agreement grants PsyLabs the right, but not the obligation, to require the Company to make a further equity investment in PsyLabs by way of a share-for-share exchange at arm’s length ...

One dose of the active compound in ayahuasca significantly improves depressive symptoms in early stages of a clinical trial, according to a new study. View on euronews ...

Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies ...

About 25 years ago, a group of pathology experts meeting in Maryland reexamined multiple accounts from the compulsive diarists of the era, and confirmed the poison was likely derived from mushrooms.